0000000000342264

AUTHOR

Stefanie Zimmer

showing 5 related works from this author

Palatal steatocystoma simplex—a rare oral finding at an even rarer location

2020

ABSTRACT Steatocystoma is a rare, benign cyst that mostly originates from a dermal sebaceous gland. It can be divided into steatocystoma multiplex—with multiple locations—and steatocystoma simplex occurring at a single site. The lesion is mostly located on the skin but can be found on other locations as well. This is the first case report of steatocystoma simplex that was found in the palate of a 37-year-old male. After resection with small safety margins and local wound dressing, no recurrence was detected during a follow-up of 1.5 years.

Sebaceous glandmedicine.medical_specialtySteatocystoma simplexintegumentary systemAcademicSubjects/MED00910business.industryCase Reportmedicine.diseaseDermatologyBenign cystsResectionLesion030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicine.anatomical_structurejscrep/090Single site030220 oncology & carcinogenesisWound dressingmedicineSurgerymedicine.symptomSteatocystoma multiplexbusinessJournal of Surgical Case Reports
researchProduct

Using the r package spatstat to assess inhibitory effects of microregional hypoxia on the infiltration of cancers of the head and neck region by cyto…

2021

Simple Summary Progress in the field of in situ proteomics allows for the simultaneous detection of multiple biomarkers within one cancer tissue specimen. As a result, biological hypotheses previously only assessable ex vivo can now be studied in human cancer tissue. However, methods for objective analysis have so far been lacking behind. In this study, we established a free, objective, and entirely open-source-based method for the analysis of multiplexed immunofluorescence specimens. This will gain further importance with the availability of more advanced multiplexing methods in the future. Abstract (1) Background: The immune system has physiological antitumor activity, which is partially …

0301 basic medicineCancer ResearchOpen-sourcespatial analysisCellBiologyArticle03 medical and health sciences0302 clinical medicineImmune systemmedicineCytotoxic T cellCancer immune evasionHead and neck cancerHypoxiacancer immune evasionRC254-282open-sourceTumor hypoxiaMultichannel im-munofluorescencehypoxiaHead and neck cancerRSpatial analysisNeoplasms. Tumors. Oncology. Including cancer and carcinogensHypoxia (medical)medicine.diseaseCTL*030104 developmental biologymedicine.anatomical_structureOncologymultichannel immunofluorescence030220 oncology & carcinogenesisCancer researchhead and neck cancermedicine.symptomInfiltration (medical)
researchProduct

PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity

2019

The potential of neuroendocrine neoplasms (NEN) to respond to checkpoint inhibitors is largely unknown and full of great expectations. Immunohistochemical (IHC) studies of programmed cell death ligand 1 (PD-L1) expression in the tumor microenvironment and its implications in predicting the response to checkpoint inhibition is a very active subject. Currently, the combined analysis of PD-L1 expression and tumor-associated immune cell (TAIC) infiltration is considered the best predictive marker of therapeutic response. Here we investigated the expression of PD-L1 on tumor cells (TC) and tumor-infiltrating immune cells (IC) by IHC in 68 NEN samples with a high proliferation rate (Ki-67 >20%…

0301 basic medicinePD-L1Cancer ResearchCD3immune checkpoint inhibitorBiologyNeuroendocrine tumorslcsh:RC254-28203 medical and health sciences0302 clinical medicineImmune systemPD-L1tumor associated immune cellmedicineT cell infiltrationOriginal ResearchTumor microenvironmentneuroendocrine neoplasmCD68neuroendocrine carcinomamedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens030104 developmental biologyOncology030220 oncology & carcinogenesisCancer researchbiology.proteinImmunohistochemistryCD8neuroendocrine tumorFrontiers in Oncology
researchProduct

Outcome and cervical metastatic spread of squamous cell cancer of the buccal mucosa, a retrospective analysis of the past 25 years.

2017

Objectives Because of the low proportion of squamous cell carcinomas (SCCs) of the buccal mucosa within the carcinomas of the oral cavity in the Western population, data concerning metastatic pattern are sparse. Therefore, this retrospective study is focusing on the occurrence of cervical metastases (CM) and the overall outcome of this tumor entity. Materials and Methods From January 1988 to October 2013, 113 patients were treated in the Department of Oral and Maxillofacial Surgery, Mainz, for an oral SCC of the cheek. Metastatic pattern and clinical parameters that are possibly associated with an increased risk for CM as well as overall outcome were analyzed. Results The average follow-up …

MaleCancer Researchmedicine.medical_specialtyPopulationBuccal mucosaGastroenterologyPathology and Forensic Medicine03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumans030223 otorhinolaryngologyeducationGrading (tumors)Survival rateAgedNeoplasm StagingRetrospective Studieseducation.field_of_studybusiness.industryHead and neck cancerMouth MucosaRetrospective cohort studyCheekmedicine.diseaseSurgerySurvival Ratemedicine.anatomical_structureCheekOtorhinolaryngologyHead and Neck Neoplasms030220 oncology & carcinogenesisOral and maxillofacial surgeryCarcinoma Squamous CellPeriodonticsNeck DissectionFemaleMouth NeoplasmsOral SurgerybusinessNeckJournal of oral pathologymedicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
researchProduct

CD15 immunostaining improves placental diagnosis of fetal hypoxia

2020

Fetal hypoxic events with unclear predictive value are a common indication for placenta examination. We evaluated whether the use of CD15 immunostaining can improve the assessment of severity and duration of fetal hypoxia.We compared placentas (37-42 gestational weeks) from stillborns/newborns with birth asphyxia (BA) and non-hypoxic newborns. Placental findings were studied in following groups: (1) acute BA (n = 11) due to placental abruption, (2) non-acute BA (n = 121) due to non-acute conditions, (3) non-BA (n = 46) in pregnancies with preeclampsia and gestational diabetes, and (4) controls (n = 30).A high expression of CD15 in feto-placental resistance vessels (FRVs) was present in non-…

AdultPlacentaPlacental FindingLewis X AntigenIntrauterine hypoxiaFetal HypoxiaPreeclampsiaAndrologyPre-EclampsiaPregnancyPlacentaHumansMedicineRetrospective StudiesAsphyxiaFetusPlacental abruptionbusiness.industryInfant NewbornObstetrics and Gynecologymedicine.diseaseImmunohistochemistryGestational diabetesmedicine.anatomical_structureReproductive Medicineembryonic structuresFemalemedicine.symptombusinessDevelopmental BiologyPlacenta
researchProduct